ATLANTA -- According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, supportive laboratory assays to diagnose lupus, specifically the antinuclear antibody (ANA ...

Anca D. Askanase, MD, MPH, shares potential highlights for the upcoming ACR Convergence 2024 and how excitement is building in the area of lupus therapeutics development, including two phase 3 ...

The EULAR/American College of Rheumatology 2019 classification criteria for systemic lupus erythematosus did not perform significantly better than the ACR 1997 and SLICC 2012 criteria, according ...

“From the ACR 1982 criteria through the EULAR/ACR 2019 criteria it has held true that we do not have a unique laboratory parameter that defines who has SLE,” they said.

The EULAR/ACR Classification Criteria Update for SLE session will take place on Tuesday, Nov. 7, at 7:30 a.m. (Ballroom 6 C), and will include the following presentations: ...

ACR: The great debate: guidelines for SLE: HCQ dose should be no more than 5 mg/kg in all patients. Presented at: 2018 ACR/ARHP Annual Meeting; October 19-24, 2018; Chicago, IL.

To develop a tool to measure treatment response in patients with childhood onset SLE, referred to by the researchers as the Childhood Lupus Improvement Index (CHILI), Brunner and colleagues ...

WASHINGTON, DC —Long-term safety and efficacy data from a 7-year continuation study were announced at the 2016 ACR/ARHP Annual Meeting that evaluated Benlysta (belimumab; GlaxoSmithKline) for ...

ACR: The great debate: guidelines for SLE: HCQ dose should be no more than 5 mg/kg in all patients. Presented at: 2018 ACR/ARHP Annual Meeting; October 19-24, 2018; Chicago, IL.